Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Michaelis

Showing results (201-210 of 214) with videos related to

Pageof 22
Sort By:
Scientific Reports|February 4, 2015
Identification of flubendazole as potential anti-neuroblastoma compound in a large cell line screenMartin Michaelis, Bishr Agha, Florian Rothweiler, et al.
Cancer Letters|April 29, 2025
Using a novel panel of drug-resistant triple-negative breast cancer cell lines to identify candidate therapeutic targets and biomarkersHelen E Grimsley, Magdalena Antczak, Ian G Reddin, et al.
The Journal of Infectious Diseases|December 31, 2009
A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1Volker Wacheck, Andrej Egorov, Franz Groiss, et al.
Plos One|April 15, 2011
Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1Brigitte M Krenn, Andrej Egorov, Ekaterina Romanovskaya-Romanko, et al.
Nature Communications|August 4, 2019
Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AMLThomas Oellerich, Constanze Schneider, Dominique Thomas, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 13, 2021
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cellsTamara Rothenburger, Dominique Thomas, Yannick Schreiber, et al.
Cancer Discovery|April 10, 2021
Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair-Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and ImmunotherapyGabriele Picco, Chiara M Cattaneo, Esmée J van Vliet, et al.
Nature Medicine|June 7, 2017
Corrigendum: SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemiaConstanze Schneider, Thomas Oellerich, Hanna-Mari Baldauf, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2005
Variable sensitivity to noxious heat is mediated by differential expression of the CGRP geneJeffrey S Mogil, Frank Miermeister, Frank Seifert, et al.
Iscience|January 16, 2023
Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platformDenisa Bojkova, Philipp Reus, Leona Panosch, et al.
Pageof 22

Showing results (201-210 of 214) with videos related to

Sort By:
Pageof 22
Scientific Reports|February 4, 2015
Identification of flubendazole as potential anti-neuroblastoma compound in a large cell line screenMartin Michaelis, Bishr Agha, Florian Rothweiler, et al.
Cancer Letters|April 29, 2025
Using a novel panel of drug-resistant triple-negative breast cancer cell lines to identify candidate therapeutic targets and biomarkersHelen E Grimsley, Magdalena Antczak, Ian G Reddin, et al.
The Journal of Infectious Diseases|December 31, 2009
A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1Volker Wacheck, Andrej Egorov, Franz Groiss, et al.
Plos One|April 15, 2011
Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1Brigitte M Krenn, Andrej Egorov, Ekaterina Romanovskaya-Romanko, et al.
Nature Communications|August 4, 2019
Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AMLThomas Oellerich, Constanze Schneider, Dominique Thomas, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 13, 2021
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cellsTamara Rothenburger, Dominique Thomas, Yannick Schreiber, et al.
Cancer Discovery|April 10, 2021
Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair-Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and ImmunotherapyGabriele Picco, Chiara M Cattaneo, Esmée J van Vliet, et al.
Nature Medicine|June 7, 2017
Corrigendum: SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemiaConstanze Schneider, Thomas Oellerich, Hanna-Mari Baldauf, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2005
Variable sensitivity to noxious heat is mediated by differential expression of the CGRP geneJeffrey S Mogil, Frank Miermeister, Frank Seifert, et al.
Iscience|January 16, 2023
Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platformDenisa Bojkova, Philipp Reus, Leona Panosch, et al.
Pageof 22